CN111616374A - 一种提高及调节运动员和宇航员身体机能的营养素 - Google Patents
一种提高及调节运动员和宇航员身体机能的营养素 Download PDFInfo
- Publication number
- CN111616374A CN111616374A CN202010718041.XA CN202010718041A CN111616374A CN 111616374 A CN111616374 A CN 111616374A CN 202010718041 A CN202010718041 A CN 202010718041A CN 111616374 A CN111616374 A CN 111616374A
- Authority
- CN
- China
- Prior art keywords
- parts
- peptide powder
- nutrient
- athletes
- improving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 34
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 28
- 230000003863 physical function Effects 0.000 title claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 51
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 51
- 241001494479 Pecora Species 0.000 claims abstract description 21
- 235000009508 confectionery Nutrition 0.000 claims abstract description 21
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 19
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 19
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 19
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 19
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 19
- 241000283690 Bos taurus Species 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 241000411851 herbal medicine Species 0.000 claims abstract description 5
- 210000000952 spleen Anatomy 0.000 claims description 20
- 210000003734 kidney Anatomy 0.000 claims description 15
- 210000004185 liver Anatomy 0.000 claims description 15
- 210000002216 heart Anatomy 0.000 claims description 13
- 210000004072 lung Anatomy 0.000 claims description 13
- 235000015278 beef Nutrition 0.000 claims description 8
- 230000036314 physical performance Effects 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- 244000197580 Poria cocos Species 0.000 claims description 5
- 235000008599 Poria cocos Nutrition 0.000 claims description 5
- 235000008434 ginseng Nutrition 0.000 claims description 5
- 241001264174 Cordyceps militaris Species 0.000 claims description 4
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 4
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 4
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 4
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 4
- 244000268590 Euryale ferox Species 0.000 claims description 4
- 235000006487 Euryale ferox Nutrition 0.000 claims description 4
- 241000133134 Saussurea Species 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 244000061508 Eriobotrya japonica Species 0.000 claims description 3
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims description 3
- 235000021336 beef liver Nutrition 0.000 claims description 3
- 244000046146 Pueraria lobata Species 0.000 claims description 2
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract description 20
- 229960000890 hydrocortisone Drugs 0.000 abstract description 10
- 230000028327 secretion Effects 0.000 abstract description 7
- 210000003205 muscle Anatomy 0.000 abstract description 6
- 238000007493 shaping process Methods 0.000 abstract description 5
- 238000003860 storage Methods 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 210000001015 abdomen Anatomy 0.000 abstract description 3
- 239000003797 essential amino acid Substances 0.000 abstract description 3
- 235000020776 essential amino acid Nutrition 0.000 abstract description 3
- 230000002496 gastric effect Effects 0.000 abstract description 3
- 230000008855 peristalsis Effects 0.000 abstract description 3
- 238000011084 recovery Methods 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 16
- 230000007812 deficiency Effects 0.000 description 11
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 241000208340 Araliaceae Species 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 208000001140 Night Blindness Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000013200 Stress disease Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 208000026500 emaciation Diseases 0.000 description 2
- 210000000750 endocrine system Anatomy 0.000 description 2
- -1 hydroxyl free radical Chemical class 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000004199 lung function Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010010970 Cor pulmonale chronic Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000026636 chronic pulmonary heart disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 208000027906 leg weakness Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明属于营养食品技术领域,特别是涉及一种提高及调节运动员和宇航员身体机能的营养素。包括以下重量份的原料,牛肽粉2份、羊肽粉2份、中草药组合物2份、麦芽糊精92份和低聚糖果2份。组分搭配更加合理,促进皮质醇的合理分泌,有效抑制顽固脂肪的存储;必要氨基酸种类齐全,口感更好,易于溶解,产品稳定性更高;更加有利于肌肉恢复,提高抵抗力,促进肠胃蠕动,促进运动员腹部塑形,更加易于消化吸收。
Description
技术领域
本发明属于营养食品技术领域,特别是涉及一种提高及调节运动员和宇航员身体机能的营养素。
背景技术
运动员或者宇航员由于工作需要,经常需要服用特殊的营养素来保持身体机能处于最佳状态。现有技术中的营养素由于蛋白含量过高,因此导致皮质醇分泌量增加,而皮质醇分泌自肾上腺皮质,是一种分解代谢激素,属于糖皮质激素,对糖代谢具有极大影响。碳水化合物摄入不足时,皮质醇会指挥身体分解脂肪、蛋白质和糖,调度比例以及控制何时分解。它既能把脂肪以甘油三酯的形式带到肌肉中,也能分解肌肉,将其转化为糖原为机体提供能量。长期高含量的皮质醇导致脂肪积累肌肉分解,从而造成服用者体重增加,甚至记忆力衰退,另外对于运动员与宇航员长期存在超负荷运动现象,到了晚年各种疾病就会突发而至,现有技术中的营养素也无法对着些病症做到很好的预防效果。
发明内容
本发明提供了一种提高及调节运动员和宇航员身体机能的营养素,有效解决了现有技术中的营养素搭配不合理的技术问题。
为了实现上述目的,本发明提供了,一种提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛肽粉2份、羊肽粉2份、中草药组合物2份、麦芽糊精92份和低聚糖果2份。
进一步的,所述提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛肺肽粉2份、羊肺肽粉2份、枇杷叶1份、蛹虫草1份、麦芽糊精92份和低聚糖果2份。
进一步的,所述提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛脾肽粉2份、羊脾肽粉2份、茯苓1份、山药1份、麦芽糊精92份和低聚糖果2份。
进一步的,所述提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛心肽粉2份、羊心肽粉2份、人参1份、酸枣仁1份、麦芽糊精92份和低聚糖果2份。
进一步的,所述提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛肾肽粉2份、羊肾肽粉2份、黄精1份、芡实1份、麦芽糊精92份和低聚糖果2份。
进一步的,所述提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛肝肽粉2份、羊肝肽粉2份、葛根1份、雪莲培养物1份、麦芽糊精92份和低聚糖果2份。
本发明相比现有技术的有益效果:相比现有技术中的营养素,组分搭配更加合理,促进皮质醇的合理分泌,有效抑制顽固脂肪的存储;必要氨基酸种类齐全,口感更好,易于溶解,产品稳定性更高;更加有利于肌肉恢复,提高抵抗力,促进肠胃蠕动,促进运动员腹部塑形,更加易于消化吸收。促进人体生理机能双向调节,增强神经系统和内分泌系统的机能,调节血压和血糖的平衡,提高机体消除自由基的能力,阻止过氧化反应;有效预防心脑血管疾病以及应激性疾病的发生。
具体实施方式
下面对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明提供了,一种提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛肽粉2份、羊肽粉2份、中草药组合物2份、麦芽糊精92份和低聚糖果2份。通过牛肽粉和羊肽粉以及中草药组合物的相互搭配,从而实现了一种搭配更加合理,营养更加均衡,高效瘦身塑形,平衡皮质醇分泌,提高抵抗力的提高及调节运动员和宇航员身体机能的营养素。其可实现对人体的心、肝、脾、肺、肾起到综合的调节作用,激发各个器官的活性。
实施例1,所述提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛肺肽粉2kg、羊肺肽粉2kg、枇杷叶1kg、蛹虫草1kg、麦芽糊精92kg和低聚糖果2kg。
牛肺肽粉味甘:具有改善肺功能、抗肺损、降低胆固醇的作用。
羊肺肽粉:具有很好的降胆固醇和抗炎作用,同时具有补肺止咳、治疗咳嗽气喘的效果。
蛹虫草:对慢性支气管炎、肺原性心脏病有显著疗效,能提高肝脏解毒能力,起护肝作用,提高身体抗病毒和抗辐射能力。
从而通过整体配方组分的组合,有效提高使用者抵抗力,改善肺功能,降低胆固醇。促进皮质醇的合理分泌,有效抑制顽固脂肪的存储。
实施例2,所述提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛脾肽粉2kg、羊脾肽粉2kg、茯苓1kg、山药1kg、麦芽糊精92kg和低聚糖果2kg。
牛脾肽粉:具有健脾开胃,治疗脾虚、食积、痞满和痔瘘等。
茯苓:具有健脾和胃;宁心安神功效;
羊脾肽粉:具有健脾开胃提高抵抗力的功效。
山药:具有抑制血脂在血管壁上沉积,从而预防心血管疾病,健脾健脑的功效。
通过几种组分的合理搭配从而起到健脾、健胃,促进皮质醇的合理分泌,有效抑制顽固脂肪的存储,提高抵抗力,更加高效的实现塑形效果。
实施例3,所述提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛心肽粉2kg、羊心肽粉2kg、人参1kg、酸枣仁1kg、麦芽糊精92kg和低聚糖果2kg。
牛心肽粉:含有丰富的钾离子,增加心脏的射血能力。对于心慌、心悸、头晕、烦躁、骨质疏松等症状都有很好的调节作用。
羊心肽粉:用于增强体质,提高机体免疫力和抗病能力,降低血压,缓解心血管疾病,同时可以增强人体的体力,抗氧化,保护视力,延缓人体的衰老,抗癌等功效。
人参:具有生津止渴、生精壮阳,临床上野生人参可以大补元气,强化人体脏器的功能。
酸枣仁:汗生津、补肝肾,养心安神、保护心肌、抗心律失常。
酸枣仁中含有丰富的皂苷可明显保护缺氧缺糖和氯丙嗪所致的心肌损伤。酸枣仁仁醇提物大鼠腹腔注射能对抗实验性心肌缺血的心电图改变。
实施例4,所述提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛肾肽粉2kg、羊肾肽粉2kg、黄精1kg、芡实1kg、麦芽糊精92kg和低聚糖果2kg。
牛肾肽粉:补肾益精强腰膝;止痹痛。主虚劳肾亏;阳痿气乏;腰膝酸软;湿痹疼痛。
羊肾肽粉:具有补肾气,益精髓。治肾虚劳损,腰脊疼痛,足膝痿弱,耳聋,消渴,阳萎,尿频,遗溺。
黄精:脾胃虚弱,体倦乏力,食欲不振,心悸,气短,肺虚燥咳,津伤口渴,消渴病,肾虚精亏,腰膝酸软;外用治脚癣。
芡实:健脾补肾、补中益气、遗精滑精。
通过组合物的结合,从而使其营养搭配更加合理,提高抵抗力,降低血脂。
实施例5,所述提高及调节运动员和宇航员身体机能的营养素,包括以下重量份的原料,牛肝肽粉2kg、羊肝肽粉2kg、葛根1kg、雪莲培养物1kg、麦芽糊精92kg和低聚糖果2kg。
牛肝肽粉:补肝、养血、明目。主虚劳赢瘦、血虚萎黄、青盲雀目、惊痫。
羊肝肽粉:味甘、苦,性凉,入肝经;有益血、补肝、明目的作用,用于血虚萎黄羸瘦、肝虚目暗昏花、雀目、青盲、障翳;可治疗夜盲、贫血;可补肺气,调水道,可治疗肺虚咳嗽、小便不利等症。其中补益效能以青色山羊肝最佳。
葛根:提高脾胃功能,能够起到健脾开胃的重要作用,提高人体肝脏的功能,能修复受损的肝细胞,减少毒素对肝脏的伤害。
雪莲培养物:具有抗风湿、消炎镇痛。一直分特异性免疫、增强体液免疫功能,清楚羟基自由基和氧基自由基的作用,另外还具有抗辐射的效果。
组分搭配更加合理,促进皮质醇的合理分泌,有效抑制顽固脂肪的存储;必要氨基酸种类齐全,口感更好,易于溶解,产品稳定性更高;更加有利于肌肉恢复,提高抵抗力,促进肠胃蠕动,促进运动员腹部塑形,更加易于消化吸收。促进人体生理机能双向调节,增强神经系统和内分泌系统的机能,调节血压和血糖的平衡,提高机体消除自由基的能力,阻止过氧化反应。有效预防心脑血管疾病以及应激性疾病的发生。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (6)
1.一种提高及调节运动员和宇航员身体机能的营养素,其特征在于:包括以下重量份的原料,牛肽粉2份、羊肽粉2份、中草药组合物2份、麦芽糊精92份和低聚糖果2份。
2.根据权利要求1所述的提高及调节运动员和宇航员身体机能的营养素,其特征在于:包括以下重量份的原料,牛肺肽粉2份、羊肺肽粉2份、枇杷叶1份、蛹虫草1份、麦芽糊精92份和低聚糖果2份。
3.根据权利要求1所述的提高及调节运动员和宇航员身体机能的营养素,其特征在于:包括以下重量份的原料,牛脾肽粉2份、羊脾肽粉2份、茯苓1份、山药1份、麦芽糊精92份和低聚糖果2份。
4.根据权利要求1所述的提高及调节运动员和宇航员身体机能的营养素,其特征在于:包括以下重量份的原料,牛心肽粉2份、羊心肽粉2份、人参1份、酸枣仁1份、麦芽糊精92份和低聚糖果2份。
5.根据权利要求1所述的提高及调节运动员和宇航员身体机能的营养素,其特征在于:包括以下重量份的原料,牛肾肽粉2份、羊肾肽粉2份、黄精1份、芡实1份、麦芽糊精92份和低聚糖果2份。
6.根据权利要求1所述的提高及调节运动员和宇航员身体机能的营养素,其特征在于:包括以下重量份的原料,牛肝肽粉2份、羊肝肽粉2份、葛根1份、雪莲培养物1份、麦芽糊精92份和低聚糖果2份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010718041.XA CN111616374A (zh) | 2020-07-23 | 2020-07-23 | 一种提高及调节运动员和宇航员身体机能的营养素 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010718041.XA CN111616374A (zh) | 2020-07-23 | 2020-07-23 | 一种提高及调节运动员和宇航员身体机能的营养素 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111616374A true CN111616374A (zh) | 2020-09-04 |
Family
ID=72267778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010718041.XA Pending CN111616374A (zh) | 2020-07-23 | 2020-07-23 | 一种提高及调节运动员和宇航员身体机能的营养素 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111616374A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114588247A (zh) * | 2022-03-18 | 2022-06-07 | 深圳海创生物科技有限公司 | 活性肽益生菌组合物及其在制备具有促进肠蠕动和/或缓解便秘作用的食品或药物中的应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107259563A (zh) * | 2017-06-08 | 2017-10-20 | 山东瑞芝生物科技有限公司 | 一种养生保健品及制备方法 |
CN108208496A (zh) * | 2016-12-12 | 2018-06-29 | 锡林郭勒盟肽好生物制品有限责任公司 | 降血糖多肽草本固体饮料及肝肽粉的制备方法 |
CN109221909A (zh) * | 2018-10-22 | 2019-01-18 | 四川环太生物科技股份有限公司 | 一种无麸质功能性食品及其制备方法 |
CN109430664A (zh) * | 2018-08-28 | 2019-03-08 | 威海养经堂医药科技有限公司 | 一种强芯肽固体饮料 |
CN110338427A (zh) * | 2018-04-08 | 2019-10-18 | 王康学 | 一种肽髓粉及其制备方法 |
CN111406950A (zh) * | 2020-04-29 | 2020-07-14 | 北京大元藏宝堂健康管理有限公司 | 一种复合多肽粉 |
-
2020
- 2020-07-23 CN CN202010718041.XA patent/CN111616374A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108208496A (zh) * | 2016-12-12 | 2018-06-29 | 锡林郭勒盟肽好生物制品有限责任公司 | 降血糖多肽草本固体饮料及肝肽粉的制备方法 |
CN107259563A (zh) * | 2017-06-08 | 2017-10-20 | 山东瑞芝生物科技有限公司 | 一种养生保健品及制备方法 |
CN110338427A (zh) * | 2018-04-08 | 2019-10-18 | 王康学 | 一种肽髓粉及其制备方法 |
CN109430664A (zh) * | 2018-08-28 | 2019-03-08 | 威海养经堂医药科技有限公司 | 一种强芯肽固体饮料 |
CN109221909A (zh) * | 2018-10-22 | 2019-01-18 | 四川环太生物科技股份有限公司 | 一种无麸质功能性食品及其制备方法 |
CN111406950A (zh) * | 2020-04-29 | 2020-07-14 | 北京大元藏宝堂健康管理有限公司 | 一种复合多肽粉 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114588247A (zh) * | 2022-03-18 | 2022-06-07 | 深圳海创生物科技有限公司 | 活性肽益生菌组合物及其在制备具有促进肠蠕动和/或缓解便秘作用的食品或药物中的应用 |
CN114588247B (zh) * | 2022-03-18 | 2024-01-26 | 深圳海创生物科技有限公司 | 活性肽益生菌组合物及其在制备具有促进肠蠕动和/或缓解便秘作用的食品或药物中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102823653A (zh) | 系列复方保健药膳奶片及其制备方法 | |
CN103431115B (zh) | 一种保健茶及其制备方法 | |
CN101168710B (zh) | 一种杜仲酒及其制备方法 | |
CN105079465A (zh) | 一种降低血糖的组合物 | |
CN108434256A (zh) | 一种养肝明目解毒排脂恢复肝脏代谢功能的中药配方 | |
CN101982082A (zh) | 一种养心草复合保健茶 | |
CN103589615B (zh) | 一种复方黄精太子参酒及其制备方法 | |
CN103859369A (zh) | 一种有助于美胸丰胸的养生保健食品配方及其制备方法 | |
CN103952278A (zh) | 玛咖矿泉酒及其制作方法 | |
CN106987512A (zh) | 一种保健酒及其制备方法 | |
CN104069390A (zh) | 一种用于增肥的中药汤剂 | |
CN105995303A (zh) | 一种红参饮品及其制备方法 | |
CN101711840B (zh) | 一种适用于癌症患者的药食两用组合物及其制备方法 | |
CN103027139A (zh) | 四季养生保健茶 | |
CN103125937A (zh) | 一种解酒护肝剂及其制备方法 | |
CN109275856A (zh) | 一种灵芝食品 | |
CN102228292B (zh) | 木耳营养饮料及其生产工艺 | |
CN111616374A (zh) | 一种提高及调节运动员和宇航员身体机能的营养素 | |
CN107156820A (zh) | 全面调理女性产后受损体质的营养食品及其制备方法 | |
CN107095098A (zh) | 一种降脂轻身复合植物饮料组合物及其制备方法 | |
CN103463625A (zh) | 养心补血营养制剂 | |
CN104491400A (zh) | 一种化疗后调补的中药药膳配方及其制备方法 | |
CN103689558A (zh) | 一种具有多种功能的养生保健食品配方及其制备方法 | |
CN111418803A (zh) | 一种养生汤的配制方法 | |
CN105311375A (zh) | 一种降低血脂的组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |